Neither agent has received MHRA marketing authorisation for the indications most commonly sought, and no formal interaction data exist for this combination
Retatrutide and cagrilintide are investigational drugs without FDA approval
However, the best medication for any individual depends on personal health factors, side effect tolerance, and lifestyle preferences
Add The New York Post on Google WASHINGTON President Trump announced Thursday that two major pharmaceutical companies will be lowering the cost of popular GLP-1 drugs used to treat diabetes and for weight loss and that the government will, in turn, expand eligibility for Medicare users
Insert chart: Glutathione efficacy studies and clinical research data visualization
As with all medications, individuals may respond differently so it is important to have options